Physician profile
James Soderstrom
NPI 1992445472
$2,697.22
in general payments reported to CMS, 2019-2025
11 companies · $503 in 2025
The $503 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $134 · 2024: $2,060 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,376 · Education: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.73 |
| Education | $321.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,383.50 | 2024 | Mako, Axsos, Inbone |
| Zimmer Biomet Holdings, INC. | $443.91 | 2025 | Oxford, Znn, Tapestry |
| Medical Device Business Services, INC. | $321.49 | 2024 | |
| Depuy Synthes Sales INC. | $219.83 | 2024 | Na, Actis, Tfn-Advance |
| Alpha Orthopedic Systems | $161.94 | 2023-2024 | |
| Vertex Pharmaceuticals Incorporated | $59.51 | 2024-2025 | |
| Heron Therapeutics, INC. | $34.04 | 2024 | Zynrelef |
| Si-Bone, INC. | $24.34 | 2025 | |
| Abbvie INC. | $17.57 | 2024 | |
| Amgen INC. | $15.59 | 2024 | Prolia, Evenity |
| Orthofix Medical, INC. | $15.50 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Soderstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.